These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 24112158

  • 1. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
    Guan HT, Wang J, Yang M, Song L, Tong XQ, Zou YH.
    Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 3. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM, Wu PH, Zhao M, Wang QJ, Huang LX, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 Nov 10; 25(11):1414-8. PubMed ID: 17094912
    [Abstract] [Full Text] [Related]

  • 4. Effect of Transcatheter Arterial Chemoembolization Combined with Argon-Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients.
    Huang M, Wang X, Bin H.
    Cell Biochem Biophys; 2015 Dec 10; 73(3):787-92. PubMed ID: 27259326
    [Abstract] [Full Text] [Related]

  • 5. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC, Huang ZL, Li W, Zhao M, Zhou QM, Xia JC, Wu PH.
    Chin J Cancer; 2010 Jun 10; 29(6):596-602. PubMed ID: 20507732
    [Abstract] [Full Text] [Related]

  • 6. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
    Huang ZM, Li W, Li S, Gao F, Zhou QM, Wu FM, He N, Pan CC, Xia JC, Wu PH, Zhao M.
    J Immunother; 2013 Jun 10; 36(5):287-93. PubMed ID: 23719239
    [Abstract] [Full Text] [Related]

  • 7. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
    Lu W, Li YH, He XF, Chen Y, Zeng QL, Qiu YR.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun 10; 22(6):524-6. PubMed ID: 12297475
    [Abstract] [Full Text] [Related]

  • 8. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS.
    Zhonghua Yi Xue Za Zhi; 2013 Sep 03; 93(33):2627-30. PubMed ID: 24360041
    [Abstract] [Full Text] [Related]

  • 9. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
    Fan WZ, Yang JY, Lü MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP.
    Zhonghua Yi Xue Za Zhi; 2011 Aug 23; 91(31):2190-4. PubMed ID: 22094036
    [Abstract] [Full Text] [Related]

  • 10. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul 23; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 11. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.
    Liver Transpl; 2011 May 23; 17(5):556-66. PubMed ID: 21506244
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC, Liu HC, Li JL, Li K, Ou SY, Yu ZY, Kong Y, Ma GA, Shao WS.
    Curr Med Res Opin; 2015 Aug 01; 31(8):1553-60. PubMed ID: 26067770
    [Abstract] [Full Text] [Related]

  • 14. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov 01; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 15. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 16. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H.
    Eur J Gastroenterol Hepatol; 2013 Feb 01; 25(2):187-94. PubMed ID: 23134976
    [Abstract] [Full Text] [Related]

  • 17. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.
    Zuo TY, Liu FY, Wang MQ, Chen XX.
    Chin Med J (Engl); 2017 Nov 20; 130(22):2666-2673. PubMed ID: 29133753
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
    Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY.
    J Clin Oncol; 2013 Feb 01; 31(4):426-32. PubMed ID: 23269991
    [Abstract] [Full Text] [Related]

  • 19. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb 01; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 20. Effect of transcatheter arterial chemoembolization on cellular immune function and regulatory T cells in patients with hepatocellular carcinoma.
    Liao J, Xiao J, Zhou Y, Liu Z, Wang C.
    Mol Med Rep; 2015 Oct 01; 12(4):6065-71. PubMed ID: 26239573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.